Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

DenmarkBack to Denmark

Clinical trials in Aarhus – page 20

631 clinical trials in Aarhus, Denmark across 5 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Aarhus at a glance
631
clinical trials
  • Research sites5
Type of trial
Recruitment status
Quick filters

631 trials in Aarhus

Open in trial search

Myocardial infarction

Recruiting

Study on the Effect of Influenza Vaccine on Heart Inflammation After Heart Attack for Patients with Myocardial Infarction

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Region Oerebro Laen

Aortic valve replacement

Recruiting

Study on Lowering INR to Reduce Bleeding in Patients with Mechanical Aortic Valves Using Warfarin, Acenocoumarol, and Phenprocoumon

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Acenocoumarol
  • Sponsor:Hamilton Health Sciences Corporation

Osteomyelitis

Recruiting

Study on Early Oral Antibiotic Treatment for Vertebral Osteomyelitis Using Cefuroxime, Dicloxacillin, and Ceftriaxone for Adult Patients

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin
  • Sponsor:Region Hovedstaden

Ovarian cancer

Recruiting

Study on Improving Ovarian Cancer Diagnosis Using Pyruvic Acid and Gadoteric Acid for Patients Suspected of Having Ovarian Cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Gadoteric Acid
  • Sponsor:Aarhus University

Systemic lupus erythematosus

Recruiting

Study on the Effectiveness and Safety of Dapirolizumab Pegol for Patients with Moderate to Severe Systemic Lupus Erythematosus

Registered drug
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Anhydrous Caffeine
  • Sponsor:UCB Biopharma

Cardiac amyloidosis

Recruiting

Study on the Effects of Dobutamine on Heart Function in Patients with Wild-type Transthyretin Amyloid Cardiomyopathy

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:65+ years
  • Substances:Dobutamine
  • Sponsor:Region Midtjylland

Colorectal cancer

Recruiting

Study on Using ctDNA to Guide Treatment in Patients with Metastatic Colorectal Cancer Using Oxaliplatin, Capecitabine, Calcium Folinate, Irinotecan, and Fluorouracil

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Region Midtjylland

Systemic lupus erythematosus

Recruiting

Study on the Long-Term Safety of Dapirolizumab Pegol for Patients with Systemic Lupus Erythematosus

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Anhydrous Caffeine
  • Sponsor:UCB Biopharma

Acute myeloid leukaemia

Recruiting

Study on the Safety and Effectiveness of Quizartinib for Children with Newly Diagnosed FLT3-ITD Positive AML and Normal NPM1

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years
  • Substances:Quizartinib Dihydrochloride
  • Sponsor:Princess Maxima Center For Pediatric Oncology

Atrial fibrillation+2

Recruiting

Study on Dapagliflozin for Reducing Atrial Fibrillation and Kidney Injury in Patients Awaiting Coronary Artery Bypass Surgery

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Region Oerebro Laen

Chronic inflammatory demyelinating polyradiculoneuropathy

Recruiting

Study on Long-term Safety and Efficacy of Efgartigimod PH20 SC in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Myocardial infarction

Recruiting

Study on Reducing Bleeding Risk in Heart Attack Patients Using Clopidogrel, Ticagrelor, and Prasugrel After Stent Procedure

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Region Hovedstaden

Other cities in Denmark

The busiest research cities in the country

All 48 cities in Denmark

Clinical research in Aarhus

What the registry says about research in the country

01 Respiratory & Pulmonary Research

Clinical investigations focusing on idiopathic pulmonary fibrosis and innovative treatments for respiratory conditions. Studies include assessment of vital capacity changes and evaluation of new therapeutic approaches.

  • Pulmonary Function Testing
  • Respiratory Disease Management
  • Treatment Efficacy Studies
02 Oncology & Cancer Research

Groundbreaking trials examining treatments for endometrial carcinoma and hepatocellular carcinoma, utilizing advanced imaging techniques and combination therapies.

  • Immunotherapy Combinations
  • Early Cancer Detection
  • Targeted Therapies
03 Neurological Disorders

Studies investigating amyotrophic lateral sclerosis and neurological conditions using innovative MRI techniques and metabolic imaging. Research includes assessment of chronic inflammatory demyelinating polyneuropathy.

  • Metabolic Imaging
  • Neurodegeneration
  • Treatment Response
04 Preventive Medicine

Vaccination studies targeting meningococcal infection and respiratory syncytial virus, with particular focus on maternal and infant health protection.

  • Vaccine Development
  • Immunogenicity Assessment
  • Maternal-Infant Protection
Back to DenmarkAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.